Stockscreener 앱 받기
3.20
0.31%
-0.010
시장 영업 전:
3.24
0.04
+1.25%
전일 마감가:
$3.21
열려 있는:
$3.16
하루 거래량:
4.19M
Relative Volume:
0.48
시가총액:
$953.51M
수익:
$6.23M
순이익/손실:
$-95.90M
주가수익비율:
-8.2051
EPS:
-0.39
순현금흐름:
$-68.47M
1주 성능:
-3.32%
1개월 성능:
-15.57%
6개월 성능:
+128.57%
1년 성능:
+254.37%
1일 변동 폭
$3.11
$3.29
1주일 범위
$2.99
$3.425
52주 변동 폭
$0.6513
$5.225
Precigen Inc Stock (PGEN) Company Profile
명칭
Precigen Inc
전화
301-556-9900
주소
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
PGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
3.20 | 1.10B | 6.23M | -95.90M | -68.47M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-15 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-03-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 개시 | JP Morgan | Neutral |
| 2022-11-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-25 | 개시 | Stifel | Buy |
| 2021-02-22 | 개시 | Wells Fargo | Overweight |
| 2021-02-18 | 개시 | B. Riley Securities | Buy |
| 2020-05-08 | 개시 | H.C. Wainwright | Buy |
모두보기
Precigen Inc 주식(PGEN)의 최신 뉴스
Why Precigen Inc. stock appeals to dividend seekersEarnings Trend Report & Weekly Return Optimization Alerts - newser.com
How Precigen Inc. stock performs in high volatility marketsJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - newser.com
Will a bounce in Precigen Inc. offer an exitGap Up & Fast Entry Momentum Trade Alerts - newser.com
Institutional scanner results for Precigen Inc.July 2025 Fed Impact & Scalable Portfolio Growth Methods - newser.com
How to integrate Precigen Inc. into portfolio analysis toolsTrade Performance Summary & Consistent Income Trade Ideas - newser.com
Precigen Says Drug for Rare Respiratory Disease Shows Durable Outcomes - MarketScreener
Precigen reports durable responses to RRP treatment in long-term data - Investing.com Nigeria
Precigen (PGEN) Showcases Promising Results for PAPZIMEOS in Tre - GuruFocus
Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis - Yahoo Finance
Using flow based indicators on Precigen Inc.Market Volume Summary & Free Technical Pattern Based Buy Signals - newser.com
Analyzing recovery setups for Precigen Inc. investorsWeekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for Precigen (NASDAQ:PGEN) - MarketBeat
How to monitor Precigen Inc. with trend dashboardsJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - newser.com
Precigen, Inc. (PGEN) Stock Analysis: A Biotech Gem With 158% Upside Potential - DirectorsTalk Interviews
Will Precigen Inc. stock deliver long term returns2025 Analyst Calls & Consistent Profit Trade Alerts - newser.com
Why Precigen Inc. stock is seen as undervaluedJuly 2025 Catalysts & Low Risk Growth Stock Ideas - newser.com
Will Precigen Inc. stock deliver consistent dividendsMarket Trend Review & Low Drawdown Trading Techniques - newser.com
Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Precigen (NASDAQ:PGEN) Trading 5.6% HigherStill a Buy? - MarketBeat
Chart based analysis of Precigen Inc. trends2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - newser.com
Is Precigen Inc. stock ready for a breakoutJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com
Volatility clustering patterns for Precigen Inc.July 2025 Patterns & Free Community Consensus Stock Picks - newser.com
Critical Analysis: Precigen (NASDAQ:PGEN) and Entera Bio (NASDAQ:ENTX) - Defense World
Have Precigen Insiders Been Selling Stock? - 富途牛牛
Precigen, Inc. (PGEN) Stock Analysis: A 147.75% Upside Beckons Biotech Investors - DirectorsTalk Interviews
What machine learning models say about Precigen Inc.July 2025 Weekly Recap & Fast Entry and Exit Trade Plans - newser.com
These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts - MSN
Insider Sell: Jeffrey Kindler Sells 174,360 Shares of Precigen I - GuruFocus
Precigen (NASDAQ:PGEN) Director Sells $243,082.80 in Stock - MarketBeat
Jeffrey Kindler Sells 106,837 Shares of Precigen (NASDAQ:PGEN) Stock - MarketBeat
Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS - MSN
Insider Buying: Phil Tennant Acquires Shares of Precigen Inc (PG - GuruFocus
Precigen (NASDAQ:PGEN) Director Randal Kirk Sells 1,809,667 Shares - MarketBeat
Cantor Fitzgerald Forecasts Weaker Earnings for Precigen - MarketBeat
Is Precigen Inc a good long term investmentEarnings Growth Projections & Free Realize Exceptional Returns - earlytimes.in
Precigen Inc (PGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Precigen Inc 주식 (PGEN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| KINDLER JEFFREY B | Director |
Sep 29 '25 |
Sale |
3.60 |
67,523 |
243,083 |
452,907 |
| KIRK RANDAL J | Director |
Sep 30 '25 |
Sale |
3.41 |
1,809,667 |
6,170,964 |
14,597,161 |
5.15%
1.45%
자본화:
|
볼륨(24시간):